P590 An interim analysis of real-world safety data from an ongoing, non-interventional, observational study of patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar, in the context of usual care with reference infliximab

Autor:	Bernd Bokemeyer, M J Cadatal, Javier P. Gisbert, Heather Fowler, Matthieu Allez, Shahrzad Moosavi, Raymond Cheung, Pamela Selema, Milan Lukas, Tibor Hlavaty
Rok vydání:	2019
Předmět:	medicine.medical_specialty business.industry Gastroenterology Context (language use) Biosimilar General Medicine medicine.disease Interim analysis Inflammatory bowel disease Infliximab Usual care Non interventional medicine Observational study Intensive care medicine business medicine.drug
Zdroj:	Journal of Crohn's and Colitis. 13:S410-S410
ISSN:	1876-4479 1873-9946
DOI:	10.1093/ecco-jcc/jjy222.714
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::75970c38624346b0fa8bc621fca35c7d https://doi.org/10.1093/ecco-jcc/jjy222.714 Zobrazit plný text záznamu